Pediatric photoscreeners in high risk patients 2012: a comparison study of Plusoptix, Iscreen and SPOT.

Robert W Arnold, Andrew W Arnold, M Diane Armitage, Janet M Shen, Tom E Hepler, Thad L Woodard
{"title":"Pediatric photoscreeners in high risk patients 2012: a comparison study of Plusoptix, Iscreen and SPOT.","authors":"Robert W Arnold,&nbsp;Andrew W Arnold,&nbsp;M Diane Armitage,&nbsp;Janet M Shen,&nbsp;Tom E Hepler,&nbsp;Thad L Woodard","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>New photoscreening models promise to detect amblyopia risk factors early in hopes of reducing permanent pediatric monocular and binocular vision impairment. The 3 commercially available interpreted photoscreeners had not yet been compared.</p><p><strong>Methods: </strong>This is a prospective, observational screening study following AAPOS guidelines on pediatric patients with and without developmental delays. 270 patients in a pediatric eye practice aged 4.7 +/- 4 years with 7% special needs. From December 2011 through March 2012, the Plusoptix, the iScreen, and the Pediavision SPOT were applied before confirmatory exam in a clinical pediatric eye practice.</p><p><strong>Results: </strong>The inconclusive rate ranged from 1-4% (iScreen) to 12% (Plusoptix). Sensitivity ranged from 72% (iScreen) to 84% (Plusoptix) and specificity ranged from 68% (SPOT) to 94% (Plusoptix). The iScreen can provide results in 99% of high risk patients.</p><p><strong>Conclusions: </strong>In this cohort with high pre-screening prevalence, the 2011 photoscreeners had favorable validation that is expected to improve with further clinical study. Pediatricians have practical technology with a recognized procedure code to assist in amblyopia reduction.</p>","PeriodicalId":72356,"journal":{"name":"Binocular vision & strabology quarterly, Simms-Romano's","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Binocular vision & strabology quarterly, Simms-Romano's","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: New photoscreening models promise to detect amblyopia risk factors early in hopes of reducing permanent pediatric monocular and binocular vision impairment. The 3 commercially available interpreted photoscreeners had not yet been compared.

Methods: This is a prospective, observational screening study following AAPOS guidelines on pediatric patients with and without developmental delays. 270 patients in a pediatric eye practice aged 4.7 +/- 4 years with 7% special needs. From December 2011 through March 2012, the Plusoptix, the iScreen, and the Pediavision SPOT were applied before confirmatory exam in a clinical pediatric eye practice.

Results: The inconclusive rate ranged from 1-4% (iScreen) to 12% (Plusoptix). Sensitivity ranged from 72% (iScreen) to 84% (Plusoptix) and specificity ranged from 68% (SPOT) to 94% (Plusoptix). The iScreen can provide results in 99% of high risk patients.

Conclusions: In this cohort with high pre-screening prevalence, the 2011 photoscreeners had favorable validation that is expected to improve with further clinical study. Pediatricians have practical technology with a recognized procedure code to assist in amblyopia reduction.

2012: Plusoptix、Iscreen和SPOT在高危患者中的儿童照相筛检比较研究。
背景:新的光筛查模型有望早期发现弱视的危险因素,以期减少儿童永久性单眼和双眼视力障碍。目前还没有对3种市售的解释光筛进行比较。方法:这是一项前瞻性、观察性筛查研究,遵循AAPOS指南,对有或无发育迟缓的儿科患者进行筛查。270例儿童眼科患者,年龄4.7±4岁,7%有特殊需求。从2011年12月到2012年3月,Plusoptix, iScreen和Pediavision SPOT在临床儿科眼科实践中应用于确认性检查之前。结果:不确定率为1-4% (iScreen) ~ 12% (Plusoptix)。灵敏度从72% (iScreen)到84% (Plusoptix),特异性从68% (SPOT)到94% (Plusoptix)。iScreen可以为99%的高风险患者提供结果。结论:在这个筛查前患病率较高的队列中,2011年photoscreeners获得了良好的验证,并有望在进一步的临床研究中得到改善。儿科医生有实用的技术和公认的程序代码来帮助减少弱视。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信